2 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 4 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Active not recruiting 1, Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Mild to Moderate Depression: new trials by email Literature Review of Mild to Moderate Depression trials Research Report on Mild to Moderate Depression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate Depression Fampridine SR, Placebo - Working Memory, Mild to Moderate Depression | Phase 2 | Recruiting | University of Basel | 38 | 2025-05-22 | 2026-10-20 |
| EMI Therapy for Depression in Hong Kong EMI, EMA - Mild to Moderate Depression | Not applicable | Unknown | The University of Hong Kong | 80 | 2024-06-30 | 2024-12-11 |
| Guided Internet-based Interventions in Primary Care Effectiveness-implementation Randomized Controlled Trial Guided internet-based cognitive behavioural therapy, Treatment as usual in Prompt Mental Health Care (TAU-PMHC) - Anxiety, Mild to Moderate Depression | Not applicable | Active not recruiting | Norwegian Institute of Public Health | 1000 | 2021-10-20 | 2024-12-11 |
| Pilot Study Using Transcranial Electrostimulation (TESA-HB) Therapy for the Treatment of Depressive Symptoms TESA-HB Transcranial Electronic Stimulation Device - Mild to Moderate Depression | Not applicable | Terminated | Annecto LLC | 12 | 2017-09-26 | 2019-02-05 |
| Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts. Phytostandard® Rhodiola-Saffron - Mild to Moderate Depression | Completed | PiLeJe | 59 | 2016-11-08 | 2018-07-17 | |
| Trial of Prompt Mental Health Care Cognitive Behavioural Therapy, Treatment as usual - Anxiety, Mild to Moderate Depression | Not applicable | Completed | Norwegian Institute of Public Health | 774 | 2015-11-09 | 2021-03-15 |
Depression (4) · Anxiety Disorders (2) · Rumination Syndrome (1)
Behavior (4) · Behavioral Symptoms (4) · Mental Disorders (3) · Digestive System Diseases (1) · Feeding and Eating Disorders (1) · Gastrointestinal Diseases (1)
Therapeutics (2) · 4-Aminopyridine (1) · Cognitive Behavioral Therapy (1)
Norwegian Institute of Public Health (2) · Annecto LLC (1) · PiLeJe (1) · The University of Hong Kong (1) · University of Basel (1)
Norway (2) · France (1) · Hong Kong (1) · Switzerland (1) · United States (1)
Robert Smith, PhD (2) · Andreas Papassotiropoulos, Prof.MD (1) · Annette Bruehl, Prof.MD (1) · Beth DuPree, MD, MD (1) · Dominique de Quervain, Prof. MD (1) · Yakov Katsnelson, MD (1)